Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use.
作者信息
Whiteside T L, Parmiani G
机构信息
Pittsburgh Cancer Institute Immunologic Monitoring and Diagnostic Laboratory, University of Pittsburgh School of Medicine, Pa. 15213-2582.
出版信息
Cancer Immunol Immunother. 1994 Jul;39(1):15-21. doi: 10.1007/BF01517175.
Abstract
摘要
相似文献
1
Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use.肿瘤浸润淋巴细胞：其表型、功能及临床应用
Cancer Immunol Immunother. 1994 Jul;39(1):15-21. doi: 10.1007/BF01517175.
2
[Tumor-infiltrating lymphocytes (TIL)].肿瘤浸润淋巴细胞（TIL）
Pol Arch Med Wewn. 1995 Jul;94(1):76-83.
3
[The antitumor effects of tumor-infiltrating lymphocytes (TIL) being proliferated in vitro].体外增殖的肿瘤浸润淋巴细胞（TIL）的抗肿瘤作用
Zhonghua Bing Li Xue Za Zhi. 1992 Apr;21(2):79-81.
4
Tracking the elusive lymphocyte: methods of detection during adoptive immunotherapy.
Immunol Invest. 2007;36(5-6):807-27. doi: 10.1080/08820130701712867.
5
Genetically modified tumor-infiltrating lymphocytes for cancer therapy.用于癌症治疗的基因改造肿瘤浸润淋巴细胞
Cancer Cells. 1991 Jul;3(7):271-4.
6
Adoptive cellular immunotherapy for cancer: interleukin-2 activated lymphocytes.
Curr Opin Oncol. 1989 Dec;1(2):249-57.
7
The Factors Affecting Expansion of Reactive Tumor Infiltrating Lymphocytes (TIL) From Bladder Cancer and Potential Therapeutic Applications.影响膀胱癌反应性肿瘤浸润淋巴细胞（TIL）扩增的因素及潜在治疗应用。
Front Immunol. 2021 Feb 25;12:628063. doi: 10.3389/fimmu.2021.628063. eCollection 2021.
8
[Isolation and expansion of glioma-infiltrating lymphocytes in vitro: an analysis of their surface phenotypes and antitumor activities].[胶质瘤浸润淋巴细胞的体外分离与扩增：其表面表型及抗肿瘤活性分析]
Hokkaido Igaku Zasshi. 1991 Nov;66(6):868-78.
9
10
Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes.白细胞介素2激活的肿瘤浸润淋巴细胞的功能和表型分析
Biotherapy. 1990;2(3):247-59. doi: 10.1007/BF02173526.
引用本文的文献
1
Minimal PD-1 expression in mouse and human NK cells under diverse conditions.在不同条件下，小鼠和人类 NK 细胞中 PD-1 的表达水平较低。
J Clin Invest. 2020 Jun 1;130(6):3051-3068. doi: 10.1172/JCI133353.
2
Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence.表征功能失调的自然杀伤细胞：评估耗竭、无反应性和衰老的临床相关性。
Front Cell Infect Microbiol. 2020 Feb 13;10:49. doi: 10.3389/fcimb.2020.00049. eCollection 2020.
3
Uterine Leiomyoma with Massive Lymphoid Infiltrate in a Patient with History of Assisted In-Vitro Fertilization.曾行辅助体外受精术患者的伴大量淋巴样浸润的子宫平滑肌瘤。
Turk Patoloji Derg. 2020;36(3):251-255. doi: 10.5146/tjpath.2019.01476.
4
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.血管内皮生长因子A（VEGF-A）调节肿瘤中CD8 + T细胞上抑制性检查点的表达。
J Exp Med. 2015 Feb 9;212(2):139-48. doi: 10.1084/jem.20140559. Epub 2015 Jan 19.
5
Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.头颈部外生性和内生型生长的鳞状细胞癌在手术后和辅助放疗后的预后相同。
Eur Arch Otorhinolaryngol. 2013 Mar;270(3):1105-14. doi: 10.1007/s00405-012-2117-1. Epub 2012 Aug 4.
6
Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model.前沿：在同源肿瘤模型中，瘤内注射负载抗原的树突状细胞可延迟和逆转 T 细胞耐受。
J Immunol. 2010 Jun 1;184(11):5954-8. doi: 10.4049/jimmunol.1000265. Epub 2010 Apr 28.
7
A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of Glioma.系统和颅内抗 CD25 免疫疗法的联合应用可延长脑胶质瘤模型小鼠的生存时间。
J Oncol. 2009;2009:963037. doi: 10.1155/2009/963037. Epub 2010 Mar 21.
8
Progress and challenges in the vaccine-based treatment of head and neck cancers.头颈部癌症疫苗治疗的进展与挑战
J Exp Clin Cancer Res. 2009 May 27;28(1):69. doi: 10.1186/1756-9966-28-69.
9
Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice.TRAMP小鼠前列腺肿瘤中病毒激活的肿瘤特异性CD8 + T细胞的快速耐受
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13003-8. doi: 10.1073/pnas.0805599105. Epub 2008 Aug 22.
10
Signaling defects in anti-tumor T cells.抗肿瘤T细胞中的信号缺陷。
Immunol Rev. 2008 Apr;222:192-205. doi: 10.1111/j.1600-065X.2008.00606.x.
本文引用的文献
1
Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.T细胞受体Vβ链基因在人黑色素瘤新鲜及培养的肿瘤浸润淋巴细胞中的应用
Int J Cancer. 1993 May 28;54(3):383-90. doi: 10.1002/ijc.2910540306.
2
Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.细胞毒性T淋巴细胞识别的肿瘤抗原：特异性免疫疗法的当前观点
Int J Cancer. 1993 May 8;54(2):177-80. doi: 10.1002/ijc.2910540202.
3
High efficiency gene transfer into primary human tumor explants without cell selection.高效将基因导入原代人肿瘤外植体且无需细胞筛选。
Cancer Res. 1993 May 15;53(10 Suppl):2221-6.
4
Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2.采用白细胞介素-2（IL-2）和经低剂量IL-2体外筛选的肿瘤浸润淋巴细胞对晚期黑色素瘤患者进行过继性免疫治疗。
Cancer Immunol Immunother. 1993 May;36(5):315-22. doi: 10.1007/BF01741170.
5
T cell recognition of human tumors: implications for molecular immunotherapy of cancer.T细胞对人类肿瘤的识别：对癌症分子免疫治疗的启示。
Clin Immunol Immunopathol. 1993 Feb;66(2):91-106. doi: 10.1006/clin.1993.1012.
6
Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion.人类消退性黑色素瘤肿瘤浸润淋巴细胞中T细胞受体变异性分析。原位T细胞克隆性扩增的证据。
J Clin Invest. 1993 Mar;91(3):1183-90. doi: 10.1172/JCI116278.
7
8
Tumor-infiltrating lymphocytes from ovarian tumors of low malignant potential.来自低恶性潜能卵巢肿瘤的肿瘤浸润淋巴细胞。
Int J Gynecol Pathol. 1993 Jan;12(1):41-50. doi: 10.1097/00004347-199301000-00006.
9
Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.肾细胞癌转移灶对自体肿瘤细胞疫苗接种及体外致敏的疫苗引流淋巴结淋巴细胞转移产生寡克隆T细胞应答的证据。
Cancer Res. 1993 Oct 15;53(20):4745-9.
10
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.自体黑色素瘤反应性细胞毒性T淋巴细胞（CTL）克隆的T细胞受体（TCR）结构：肿瘤浸润淋巴细胞在体内过度表达一种由HLA - A2限制性且黑色素细胞谱系特异性CTL克隆所使用的TCRβ链序列。
J Exp Med. 1993 Oct 1;178(4):1231-46. doi: 10.1084/jem.178.4.1231.
Zotero 插件